Researchers sought to determine whether azacitidine plus venetoclax would be effective in patients with AML transformed from MDS previously treated with azacitidine monotherapy.

USA News Group News Commentary Issued on behalf of GT Biopharma, Inc. VANCOUVER, Oct. 17, 2025 /PRNewswire/ -- ...

Biomarker-driven drug development accelerates across oncology as companies advance novel mechanisms targeting previously ...

Complications from myelodysplastic syndromes (MDS), like anemia or fatigue, can occur because the bone marrow isn’t making enough healthy or functional blood cells. Myelodysplastic syndromes (MDS) are ...

SAN ANTONIO – Thanks to efforts from doctors, researchers, health care providers and nonprofits such as Blood Cancer United, certain types of blood cancers are no longer the terminal diagnoses that ...

N6-methyladenosine (m6A) modification, mainly controlled by the m6A methyltransferase METTL3, is crucial for RNA regulation and the development of leukemia. However, how METTL3 stability and function ...

Receiving a myelodysplastic syndromes (MDS) diagnosis isn’t easy, and talking with your family about it can feel overwhelming. Here’s what you need to know to answer some of the most common questions.

In the first-line treatment of higher-risk myelodysplastic syndromes (MDS), the combination of venetoclax with azacitidine fell short of the primary endpoint of a reduction in mortality compared with ...

Kate Middleton is living her life like it’s golden. After all, the Princess of Wales is embracing being a caramel blonde. As she and husband Prince William—who share kids Prince George, 12, Princess ...